FORTIS
Fortis Healthcare Limited (FORTIS) Stock Analysis
Fortis Healthcare Limited is a leading Indian hospital chain operating multi-specialty facilities across the country. It provides inpatient, outpatient, and diagnostic healthcare services. The company serves patients through owned and managed hospitals. It is listed on Indian stock exchanges.
Healthcare › Medical Care Facilities
₹825.00
+7.98% 1W | -15.20% 52W
Market Cap
62.3k CR
P/E Ratio
60
52W High
₹1010.1
52W Low
₹705
Div. Yield
0.12%
Beta
0.7
50 DMA
₹792.7
200 DMA
₹888.8
Profit Margin
10.5%
Inst. Own.
51.5%
🚀 BREAKOUT
🚀 BREAKOUT
Fundamentals
Profit & Loss
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,770 | 1,680 | 1,786 | 1,859 | 1,988 | 1,928 | 2,007 | 2,167 | 2,331 | 2,265 | 2,365 | 2,545 | 2,735 |
| YoY Sales growth | +10% | +8% | +9% | +12% | +12% | +15% | +12% | +17% | +17% | +17% | +18% | +17% | +17% |
| Expenses | 1,440 | 1,396 | 1,405 | 1,516 | 1,554 | 1,553 | 1,572 | 1,676 | 1,775 | 1,759 | 1,832 | 2,008 | 2,112 |
| Operating Profit | 330 | 284 | 381 | 343 | 435 | 375 | 435 | 491 | 556 | 506 | 532 | 537 | 623 |
| OPM % | 19% | 17% | 21% | 18% | 22% | 19% | 22% | 23% | 24% | 22% | 23% | 21% | 23% |
| Other Income | 18 | 19 | 17 | 14 | -42 | 47 | -29 | 31 | 50 | -34 | -2 | 28 | 16 |
| Interest | 32 | 33 | 35 | 35 | 36 | 45 | 68 | 70 | 75 | 86 | 84 | 80 | 78 |
| Depreciation | 84 | 87 | 92 | 91 | 95 | 97 | 102 | 101 | 106 | 120 | 122 | 122 | 128 |
| Profit before tax | 233 | 183 | 271 | 230 | 261 | 279 | 237 | 351 | 425 | 266 | 324 | 363 | 432 |
| Tax % | 21% | 27% | 25% | 24% | 26% | 9% | 21% | 24% | 23% | 26% | 16% | 25% | 26% |
| Net Profit | 184 | 134 | 203 | 174 | 193 | 254 | 188 | 267 | 329 | 197 | 271 | 273 | 320 |
| EPS in Rs | 2.30 | 1.78 | 2.37 | 2.20 | 2.34 | 3.28 | 2.44 | 3.45 | 4.26 | 2.57 | 3.52 | 3.53 | 4.14 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,966 | 4,199 | 4,574 | 4,561 | 4,469 | 4,632 | 4,030 | 5,718 | 6,298 | 6,893 | 7,783 | 9,128 | 9,910 |
| Sales growth | +14% | +6% | +9% | -0% | -2% | +4% | -13% | +42% | +10% | +9% | +13% | +17% | +18% |
| Expenses | 3,857 | 4,106 | 4,220 | 4,287 | 4,238 | 4,022 | 3,626 | 4,649 | 5,196 | 5,625 | 6,195 | 7,043 | 7,711 |
| Operating Profit | 109 | 92 | 354 | 274 | 231 | 610 | 404 | 1,069 | 1,101 | 1,268 | 1,588 | 2,085 | 2,198 |
| OPM % | 2.8% | 2.2% | 8% | 6% | 5% | 13% | 10% | 19% | 17% | 18% | 20% | 23% | 22% |
| Other Income | 92 | 299 | 649 | -689 | 228 | 126 | 95 | 367 | 157 | 64 | -11 | 45 | 8 |
| Interest | 152 | 133 | 229 | 258 | 337 | 205 | 166 | 147 | 129 | 131 | 184 | 314 | 329 |
| Depreciation | 235 | 225 | 222 | 239 | 233 | 292 | 291 | 301 | 316 | 342 | 386 | 449 | 492 |
| Profit before tax | -185 | 34 | 552 | -912 | -110 | 239 | 43 | 988 | 814 | 858 | 1,007 | 1,366 | 1,385 |
| Tax % | 2% | -24% | 13% | 2% | 103% | 62% | 230% | 20% | 22% | 25% | 20% | 22% | |
| Net Profit | -130 | 42 | 479 | -934 | -224 | 91 | -56 | 790 | 633 | 645 | 809 | 1,064 | 1,062 |
| EPS in Rs | -3.10 | 0.40 | 8.14 | -19.46 | -3.96 | 0.77 | -1.45 | 7.35 | 7.80 | 7.93 | 10.26 | 13.80 | 13.76 |
| Dividend Payout % | -1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 13% | 13% | 10% | 7% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 13.0% | 18.0% | 8.0% |
| Profit CAGR | 27.0% | 64.0% | 60.0% |
Shareholding Pattern
Promoters31.17%
FIIs27.90%
DIIs29.14%
Public11.79%
Promoters31.17%
FIIs27.84%
DIIs29.33%
Public11.65%
Promoters31.17%
FIIs25.98%
DIIs31.35%
Public11.50%
Promoters31.17%
FIIs25.20%
DIIs32.23%
Public11.40%
Promoters31.17%
FIIs23.20%
DIIs34.45%
Public11.18%
Promoters31.17%
FIIs31.22%
DIIs20.69%
Public16.92%
Promoters31.17%
FIIs23.24%
DIIs31.14%
Public14.44%
Promoters31.17%
FIIs27.40%
DIIs29.46%
Public11.98%
Promoters31.17%
FIIs25.98%
DIIs31.35%
Public11.50%
Promoters31.17%
FIIs23.20%
DIIs34.45%
Public11.18%
FORTIS
Holdings Analysis
Key strengths & risk signals
69
Overall
73
Fundamental
66
Technical
Risks (3)
NEGLIGIBLE DIVIDEND! 0.12% yield - little to no income.
WEAK YEAR! Stock declined 15.2% in the last year.
LOWER HALF! Trading at 39.3% of 52W range - weakness visible.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BREAKOUT! Stock has broken above resistance levels with momentum.
LOW VOLATILITY! Beta of 0.70 - stable stock, less market risk.
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 2,028,124 vs down days: 2,017,025. Ratio: 1.01x
Fundamental & Technical Analysis
69Overall
73Fundamental
66Technical
Fundamental Breakdown
Growth Quality
26/30
Revenue CAGR: 13.3% (GOOD, 11/15). Profit CAGR: 21.0% (EXCELLENT, 15/15).
Profit Margin
5/10
DECENT EFFICIENCY! 10.5% profit margin - acceptable profitability.
PEG Valuation
5/10
OVERVALUED! PEG of 2.86 means expensive relative to growth rate.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.12% yield - little to no income.
Debt to Equity
8/10
LOW DEBT! D/E of 0.33 - strong balance sheet.
Public Holding
16/20
LESS PUBLIC HOLDING! 16.65% public ownership - good institutional/promoter control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
5/10
BEARISH TREND! 50-day average (792.7) is below 200-day average (888.8) - negative signal.
Price Position
6/10
MIXED POSITION! Current price (825.0) above 50-day but below 200-day.
Trend Pattern
20/20
BREAKOUT! Stock has broken above resistance levels with momentum.
52W Performance
2/10
WEAK YEAR! Stock declined 15.2% in the last year.
Volume Sentiment
20/30
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 2,028,124 vs down days: 2,017,025. Ratio: 1.01x
RSI
3/5
NEUTRAL! RSI at 57.4 - balanced momentum.
52W Range
2/5
LOWER HALF! Trading at 39.3% of 52W range - weakness visible.
Momentum
3/5
MIXED MOMENTUM! Price growth is inconsistent - 8.0% (1 week), 11.8% (1 month), -9.2% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.70 - stable stock, less market risk.
FORTIS
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q2FY272026-11-10 | Concall PDF | |
| Q1FY272026-09-10 | Concall PDF | |
| Q4FY262026-05-29 | Concall PDF | |
| Q3FY262026-02-20 | Concall PDF | |
| Q2FY262025-11-17 | Concall PDF |
Peer Comparison
Healthcare · Medical Care Facilities · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FORTIS | ₹825.00 | 60 | 10.5% | 13.3% | 21.0% | -15.2% | 69 | BREAKOUT | -3.0% | +17.3% | +17.3% | +7.5% |
| ASTERDM | ₹779.30 | 100.3 | 7.2% | 15.7% | -3.0% | +9.9% | 63 | BREAKOUT | – | +1,527.3% | – | +115.9% |
| MEDANTA | ₹1,480.20 | 64.4 | 12.2% | 17.2% | 19.5% | +18.4% | 65 | APPROACHING RESISTANCE | +39.3% | +39.1% | +33.6% | +12.6% |
| NH | ₹1,943.70 | 45.3 | 8.4% | 20.5% | 9.9% | -6.2% | 70 | BREAKOUT | +16.5% | +45.3% | +73.0% | +6.0% |
| KIMS | ₹795.60 | 154.2 | 4.6% | 21.3% | -10.5% | +12.8% | 57 | APPROACHING RESISTANCE | +12.1% | +80.7% | +39.9% | +14.0% |
| MAXHEALTH | ₹1,081.00 | 77.8 | 15.1% | 22.4% | 9.3% | -12.5% | 70 | BREAKOUT | -15.6% | +28.5% | +20.3% | +8.6% |
| APOLLOHOSP | ₹9,200.00 | 58.8 | 8.1% | 14.8% | 33.3% | +18.8% | 63 | APPROACHING RESISTANCE | – | +8.5% | +23.0% | +8.1% |
| RAINBOW | ₹1,259.70 | 43.7 | 15.2% | 13.1% | 9.7% | -6.0% | 59 | CONSOLIDATING DOWN | +9.2% | +35.5% | +23.2% | +16.6% |
Data from TradeAlone · Updated daily
FORTIS News
Fortis Healthcare Limited (fortis) Announces Q2 FY27 Financial Results: Revenue Up 17.3%, PAT Margin Down to 11.7%2026-11-05Fortis Healthcare Limited Acquires Suguna Hospital in Bengaluru for INR 277 Crores2026-10-28Fortis Healthcare Limited (fortis) Signs Agreements to Provide Healthcare Services to New Super Specialty Hospital in Delhi2026-09-16Fortis Healthcare Limited (NSE: FORTIS) breaks below support, falls 5% intraday2026-08-12Fortis Healthcare Limited (FORTIS) gains 5% intraday, nears resistance2026-08-07Fortis Healthcare Limited (fortis) Q1 FY27: Revenue Up 17.5%, Operating Ebitda Margin at 22.3%2026-08-06Fortis Healthcare Limited Appoints Vijender Singh as Managing Director & CEO of Agilus Diagnostics2026-07-20Fortis Healthcare Limited (fortis) Expands Presence in Odisha with New 300-bed Hospital2026-07-03Fortis Healthcare Limited (fortis) Q4 FY26: Revenue Up 17.8%, PAT Surges 44.2%2026-05-22
